AEF0117
Product Specifications
UNSPSC Description
AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). AEF0117 plays an important role in Cannabis use disorder (CUD)[1].
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/aef0117.html
Solubility
DMF : 10 mg/mL (ultrasonic)|DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
C[C@@]12[C@]3([H])[C@](CC=C1C[C@H](CC2)OCC4=CC=C(C=C4)OC)([H])[C@@]5([H])[C@](CC3)([C@H](CC5)C(C)=O)C
Molecular Weight
436.63
References & Citations
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156831/AEF0117-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156831/AEF0117-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1610878-71-1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
USP3, NT (Ubiquitin Carboxyl-terminal Hydrolase 3, Ubiquitin Thiolesterase 3, Ubiquitin-specific-processing Protease 3, Deubiquitinating Enzyme 3) (MaxLight 490)
USP3, NT (Ubiquitin Carboxyl-terminal Hydrolase 3, Ubiquitin Thiolesterase 3, Ubiquitin-specific-processing Protease 3, Deubiquitinating Enzyme 3) (MaxLight 490)
